immunitoAI
AI-driven antibody design for therapeutic development.
immunitoAI’s platform generates novel antibody sequences optimized for target binding, specificity, and developability. Researchers specify disease targets and receive candidate molecules in silico, accelerating lead discovery and reducing lab screening time.
Related
A&B Smart Materials
A&B Smart Materials
Biodegradable smart hydrogels for passive cooling.
A51
A51
Programmable RNA therapeutics platform.
Accurx
Accurx
Powering communications in the healthcare sector.
Ackcio
Ackcio
Mesh wireless monitoring for sensors.
Adbrain
Adbrain
Cross-device identity for personalized marketing.
Cofounder
Cofounder
Affable
Affable
AI analytics for influencer campaigns.